Abstract Balloon sinuplasty is a technique in endoscopic sinus surgery that involves minimally invasive procedures to dilate the obstructed or stenosed anatomical sinus pathways. Procedure is derived from the well-recognized techinique of angioplasty. This article highlights the procedural methods with review of literature and my personal experience in balloon sinupalsty.
Introduction
Balloon sinuplasty is a technique of dilating the sinus ostia without cutting the mucosa or surrounding structures. The technique is derived from the well-established angioplasty used in arterial stenosis.
It is a performed by a flexible tool (balloon catheter) that enables surgeons to endoscopically create an opening in a patient's blocked or significantly narrowed sinus ostia and transition spaces, while maximizing tissue preservation and minimizing iatrogenic mucosal injury.
The balloon sinuplasty has become a widely debated topic in the field of rhinology. Both doctors and patients are becoming more and more aware of its usefulness and advantages. The technique was first started in 2002.
Since its introduction there have been many modifications that have made the procedure more acceptable to both surgeons and their patients. The disadvantage of radiation exposure by fluoroscopy is now replaced by the lumiview that is radiation-free and is more acceptable, while equally efficient in locating the correct sinus [1] .
Sinuplasty in itself involves a simple catheter to find the pathway; a balloon is then railroaded on it and inflated to different pressures while in place to dilate the sinus ostium.
To date, the balloon-dilating catheter has been used in over 100,000 sinuses in 30,000 patients, and over 3,000 otolaryngologists have been certified by Acclarent, Inc. (Menlo Park, CA) through cadaver instructional courses.
Its use may be limited to the patients with limited sinus disease but more and more surgeons are using the procedure in combination with the parts of traditional functional sinus surgery. This combination is called hybrid balloon sinuplasty. (July-September 2010) 62(3) (Rhinology): [225] [226] [227] [228] been presented in the otolaryngology/rhinology meetings about 13 years ago [2] . Fogarty biliary tract balloon catheter however cannot fracture bones, which constitute the paranasal sinus air cells. The technique was thus mainly applied to revise postoperative re-stenosis.
Balloon sinuplasty has also had its opponents with arguments raised from development of mucocoele, imbedding infection into the bone causing osteitis and other complications.
Lanza and Kennedy [3] stated that balloon sinuplasty should not be used as the only surgical technique in cases of chronic polypoidal sinusitis, which is a disease that otolaryngologists manage more often than isolated inflammations of the paranasal sinuses. Lanza and Kennedy further indicated in their comment that two other postulated problems could also arise, that of microbes being seeded into mucosal and bony tissue that was compressed by balloon dilatation possibly leading to mucositis and osteitis and that of development of mucoceles from the crushed air cells in the long-term. However since its introduction there are a number of publications that have proved its safety and long-term follow-ups with successful results.
Bolger et al. in 2007 [4] published the results of a prospective multicenter analysis. They found that initial evidence of the safety and effectiveness of balloon catheter sinusotomy has been encouraging. The 24-week results of the prospective multicenter CLEAR (Clinical Evaluation to confirm sAfety and efficacy of sinuplasty in the paRanasal sinuses) study of 115 patients included a favorable safety profile with zero adverse events, durability of patency in 98% of observed ostia, and significant improvement in patient symptoms. One year after surgery, the impressive ostial patency and symptom improvement results remained durable; in addition, there was a significant resolution of disease by CT examination [5] .
Patency was determined by endoscopic examination. 80.5% (247/307) had patent osita and non-patency was observed in 1.6% (5/307) of cases. 17.9% (55/307) of cases, patency could not be assessed endoscopically due to sinus anatomy preservation inherent to using the balloon catheter as the single modality in management.
In their follow up study Weiss et al. [6] in 65 patients with 2 years follow-up studies found very favorable results and concluded that the results from this 2-year study indicate long-term durability of clinical outcomes of balloon catheter sinusotomy used in endoscopic sinus surgery (ESS). The impressive improvement in patient symptoms previously reported at 24 weeks and 1 year is sustained through 2 years postsurgery. The resolution of disease on CT scan previously observed at 1 year is also sustained in this 2-year analysis [6] .
The patients had undergone an initial history and physical examination at the time of inclusion in the study. Standard ESS and postoperative care was provided.
Patients were assessed for any adverse event; symptom improvement, demonstrated by the Sinonasal Outcome Test (SNOT-20) [7] and standardized patient questionnaire regarding postoperative changes in symptoms; and radiographic evidence of disease by CT scans.
The SNOT-20 rates the severity of 20 symptoms over the preceding 2 weeks, on a six-point scale (from 0 = "no problem" to 5 = "problem as bad as it can be"). If a patient neglected to rate more than five of the symptoms at a particular visit, that visit's test was not used. The standardized patient questionnaire rates sinusitis symptoms compared with those before treatment on a five-point scale: significantly improved = 2, improved = 1, same = 0, worse = 1, significantly worse = 2. The percentage of patients reporting improvement (scores of 1 or 2) was presented. CT scans were analyzed by the investigators using the Lund-MacKay radiographic staging system [8] .
The three CLEAR studies have systematically demonstrated a statistically significant (p = 0.001) and clinically significant (>0.8) improvement in SNOT-20 symptom scores at every time point (postoperative 1 week, 12 weeks, 24 weeks, 1 year and 2 years). This long-term durability of symptom improvement indicates that initial symptom improvement can be maintained long-term.
Patency rates for balloon catheter sinusotomy have been already studied extensively in the 24-week and 1-year CLEAR studies. As the typical wound-healing process occurs over the initial 3-4 months after tissue injury, by which time collagen remodeling has leveled off, evidence of ostial restenosis would be definitive at the 24-week, and certainly 1-year, time point [9, 10] .
Furthermore, in a recent study of frontal ostial restenosis using traditional endoscopic sinus surgical tools, in which 29% of patients (22 of 77) had significant restenosis by endoscopic examination, all cases of restenosis occurred within the first 12 months postsurgery [11] .
While these patients may have had a different extent of disease, this study still speaks to the time period of 12 months as to when much of frontal sinus stenosis will occur Bolger et al. [3] . Has shown a very low rate of complications in their series of 358 sinuses. The possible long-term effect of mucocoele formation from a crushed air cell cannot be answered now for a procedure that is <10 years from inception. However iatrogenic mucocoele formation has also arisen following conventional ESS. The risk probably is not more than seen in conventional surgery of sinuses.
Discussion
If functional ESS is considered as minimally invasive surgery when compared to the traditional Caldwell-Luc procedure and external ethmoidectomies of the past; then, balloon sinuplasty may be considered as micro-minimally invasive surgery achieving the aims of functional ESS without the need to violate the structures surrounding targeted ostia.
The preservation of mucociliary flow is one of the tenets of ESS, and adhering to this dictum is what separates ESS from functional ESS. To achieve the principles of functional ESS, I think balloon is the part of armamentarium in ESS that enables you to achieve these goals.
Cost constraint is an important issue particularly due to single use of the balloons. With the exception of microdebrider blades, most instrumentation commonly used in ESS is not disposable. There is an array of instrumentation required to use this technique that is not reusable between patients; a standard bilateral case for six sinuses (two each of sphenoid, frontal and maxillary sinuses) typically uses three introducing cannulas, one guide wire and one balloon. This increases the cost of disposable instrumentation approximately to $1,200. Intraoperative fluoroscopy is no longer an additional expense; as a lighted guidewire has been developed that is used for transillumination to locate the sinus. Despite these up-front costs, there are potential savings associated with this technique. First, there may be an overall reduction of operating room time, which decreases charges from the operating facility as well as from the anesthesia team. There is also a reduction in the number of debridements commonly performed in the postoperative period in traditional ESS cases, as there is less mucosal disruption.
Any cost analysis of this device should include all of these details; unfortunately, this would be a difficult task as surgeons' procedure lengths and number of postoperative debridements vary widely and are not well reported in the literature.
The procedure and the material costs of balloon sinuplasty are not presently undertaken by medical insurance in Europe. It is however covered by medical insurance in some parts of New Zealand and it is expected that soon the major insurance providers will approve to cover the costs as the process is being reviewed while I am writing this article.
I have started doing balloon sinuplasties not long ago after getting myself credentialed to do the procedure from acclarent organized 2-day course in Melbourne. I have so for done about 12 procedures and have been convinced that the procedure has its definite advantages and so for the outcomes have been encouraging, however the follow up of my series is still short and difficult to give any conclusive comments (Fig. 1) . International literature however is very convincing as regards its advantages.
Most of my cases (70%) have been revision surgeries and most of these have undergone hybrid procedures. Half the patients were also associated with polyps.
Maxillary antrostomy can be performed without removal of the uncinate process. Function of the uncinate process has been debated, there may be some unrecognized benefit to this "mudflap"-like structure that protects the middle meatus by acting as a physical barrier to airborne pathogens while diverting airflow away from the middle meatus and osteomeatal complex. Perhaps the absence of the uncinate process could help explain why the microbial flora is so different in chronic rhinosinusitis patients who have been operated upon than those who have not been operated [1] .
Balloon sinuplasty is an excellent tool to treat frontal sinus disease without causing any complications and I feel that if you are dealing with a recurrent frontal sinus disease and you think patient would need a Lothrop procedure, I will recommend trying a balloon sinuplasty before you proceed to a very extensive frontal sinus procedure like Lothrops.
I am glad to see that the technique is being undertaken by most of the rhinologists in the world and it is encouraging to see that the developing world with its cost strains on disposable items of surgery is not far behind in offering it to their patients [12] .
Last of all I think balloons are a part of minimal invasive ESS armamentarium and more and more surgeons should use this as a part of the whole armamentarium in treating sinus disease surgically.
